Transparency too little, too late? Why and how Health Canada should make clinical data and regulatory decision-making open to scrutiny in the face of COVID-19

Creative Commons License

Edmonds S., Macgregor A., Doll A., Vural İ., Graham J., Fierlbeck K., ...Daha Fazla

Journal of Law and the Biosciences, cilt.7, sa.1, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 1
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1093/jlb/lsaa083
  • Dergi Adı: Journal of Law and the Biosciences
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, BIOSIS, EBSCO Legal Collection, EBSCO Legal Source, Directory of Open Access Journals
  • Anahtar Kelimeler: pharmaceutical regulation, transparency, COVID-19, vaccines and drugs, pandemic
  • Orta Doğu Teknik Üniversitesi Adresli: Hayır